Ignite Creation Date:
2025-12-24 @ 10:22 PM
Ignite Modification Date:
2026-01-02 @ 9:38 PM
Study NCT ID:
NCT00919035
Status:
COMPLETED
Last Update Posted:
2014-06-30
First Post:
2009-06-10
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Single Agent Temsirolimus (Torisel®) in Chemotherapy-naïve Castration-Resistant Prostate Cancer Patients
Sponsor:
Oncology Specialists, S.C.
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
OSRI 0901
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |